GL1X · GenesisL1 explorer

MolNFT v1 · #90602 · protein

HCV NS5B polymerase inhibitors: tri-substituted acylhydrazines as tertiary amide bioisosteres

4EO6 · RNA-directed RNA polymerase: “HCV NS5B polymerase inhibitors: tri-substituted acylhydrazines as tertiary amide bioisosteres”. X-ray diffraction, 1 ligand (0S2), 12 pockets (best druggability 0.80). MolNFT v1 #90602 on GenesisL1: 3D…

PDB
4EO6
Type
protein
Length
1,117 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
0S2
Pockets
12 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein55749% helix, 15% strandP26663
BRNA-directed RNA polymerase (EC 2.7.7.48)protein56049% helix, 16% strandP26663

Ligands and binding sites

  • 0S2 · 5-(3,3-dimethylbut-1-yn-1-yl)-3-{[(trans-4-methylcyclohexyl)carbonyl](propan-2-yl)amino}thiophene-2-carboxylic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111060.800.8186empty
210450.800.8177empty
311640.760.7968empty
41170.490.8021empty
51080.480.8021empty

Interfaces

1 interface between chains.

  • A–B · 562 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 4EO6 · HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.